Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TCF7L2 gene polymorphism is linked to alopecia areata, but it doesn't affect the success of PRP or conventional treatments.

Both finasteride and drospirenone effectively manage PCOS symptoms, but drospirenone is more effective in reducing ovarian volume and androgen levels.

Orlistat might block the body's ability to absorb thyroid medication.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Platelet-rich plasma shows promise for treating dry eye disease, but more standardized trials are needed.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

New treatments like PBMC, G-CSF, and PRP show promise for helping with repeated implantation failure.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

New therapies are being developed that target integrin pathways to treat various diseases.

Tralokinumab effectively improved atopic dermatitis symptoms in most patients, but some stopped due to side effects like hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

TRPV4 channels in the skin may enhance the effects of acupuncture.

Oral tacrolimus may be a potential treatment for hair loss that doesn't respond to corticosteroids.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Triamcinolone hexacetonide is effective but has side effects, while PRP and minoxidil are safer alternatives for treating alopecia areata.

Etanercept effectively treated a severe skin condition when other treatments failed.

Cyproterone acetate is effective for treating hirsutism and acne in women by blocking androgens in the skin and also works as a contraceptive.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Tacrolimus ointment is effective for various skin conditions but needs more research for long-term effects.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Bedaquiline, Telmisartan, Diosmin, Azelastine, and Adapalene may be effective treatments for onchocerciasis.

The combination of PRP and triamcinolone injections improved hair growth in a man with alopecia areata.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.